| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 28, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 28, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/13/2024 | $10.00 | Buy | The Benchmark Company |
| 12/5/2023 | $9.00 | Market Perform | BMO Capital Markets |
| 10/20/2023 | $8.00 | Neutral | UBS |
| 9/12/2023 | $9.00 | Hold | Berenberg |
| 11/14/2022 | $9.00 | Overweight | Stephens |
| 8/10/2022 | $19.00 → $13.00 | Buy → Neutral | Citigroup |
| 8/10/2022 | $21.00 → $13.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 7/22/2022 | $20.00 → $15.00 | Outperform → Neutral | Credit Suisse |